Aquamycetin en es it fr

Aquamycetin Brand names, Aquamycetin Analogs

Aquamycetin Brand Names Mixture

  • No information avaliable

Aquamycetin Chemical_Formula

C11H12Cl2N2O5

Aquamycetin RX_link

http://www.rxlist.com/cgi/generic3/chloramphenicol.htm

Aquamycetin fda sheet

Aquamycetin FDA

Aquamycetin msds (material safety sheet)

Aquamycetin MSDS

Aquamycetin Synthesis Reference

No information avaliable

Aquamycetin Molecular Weight

323.129 g/mol

Aquamycetin Melting Point

150.5 oC

Aquamycetin H2O Solubility

2500 mg/L (at 25 °C)

Aquamycetin State

Solid

Aquamycetin LogP

1.476

Aquamycetin Dosage Forms

Capsule; Drops; Liquid; Ointment; Powder; Solution; Suspension; Tablet

Aquamycetin Indication

Used in treatment of cholera, as it destroys the vibrios and decreases the diarrhea. It is effective against tetracycline-resistant vibrios. It is also used in eye drops or ointment to treat bacterial conjunctivitis.

Aquamycetin Pharmacology

Chloramphenicol is a broad-spectrum antibiotic that was derived from the bacterium Streptomyces venezuelae and is now produced synthetically. Chloramphenicol is effective against a wide variety of microorganisms, but due to serious side-effects (e.g., damage to the bone marrow, including aplastic anemia) in humans, it is usually reserved for the treatment of serious and life-threatening infections (e.g., typhoid fever). Chloramphenicol is bacteriostatic but may be bactericidal in high concentrations or when used against highly susceptible organisms. Chloramphenicol stops bacterial growth by binding to the bacterial ribosome (blocking peptidyl transferase) and inhibiting protein synthesis.

Aquamycetin Absorption

Rapidly and completely absorbed from gastrointestinal tract following oral administration (bioavailability 80%). Well absorbed following intramuscular administration (bioavailability 70%). Intraocular and some systemic absorption also occurs after topical application to the eye.

Aquamycetin side effects and Toxicity

Oral, mouse: LD50 = 1500 mg/kg; Oral, rat: LD50 = 2500 mg/kg. Toxic reactions including fatalities have occurred in the premature and newborn; the signs and symptoms associated with these reactions have been referred to as the gray syndrome. Symptoms include (in order of appearance) abdominal distension with or without emesis, progressive pallid cyanosis, vasomotor collapse frequently accompanied by irregular respiration, and death within a few hours of onset of these symptoms.

Aquamycetin Patient Information

No information avaliable

Aquamycetin Organisms Affected

Enteric bacteria and other eubacteria